DOI: 10.1128/AAC.02466-18
Article Information
PubMed
Published By
History
- Received November 22, 2018
- Returned for modification December 29, 2018
- Accepted March 2, 2019
- Published online May 24, 2019.
Copyright & Usage
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (April 08, 2019).
- You are viewing the most recent version of this article.
Author Information
- aSection of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
- bKarolinska Institutet, Department of Laboratory Medicine, Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden
- cDepartment of Pharmaceutical Biosciences, Uppsala University, Sweden
- Address correspondence to S. Kurland, siri.kurland{at}medsci.uu.se.
Citation Kurland S, Furebring M, Löwdin E, Eliasson E, Nielsen EI, Sjölin J. 2019. Pharmacokinetics of caspofungin in critically ill patients in relation to liver dysfunction: differential impact of plasma albumin and bilirubin levels. Antimicrob Agents Chemother 63:e02466-18. https://doi.org/10.1128/AAC.02466-18.
